As of October 2024 ImmunoPrecise Antibodies has 24.90M shares outstanding, a increase of 26.46% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 24.90M | 26.46% |
2022 | 19.69M | 19.51% |
2021 | 16.47M | 20.88% |
2020 | 13.63M | - |